Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 66

1.

Adenovirus IL-13-induced airway disease in mice: a corticosteroid-resistant model of severe asthma.

Therien AG, Bernier V, Weicker S, Tawa P, Falgueyret JP, Mathieu MC, Honsberger J, Pomerleau V, Robichaud A, Stocco R, Dufresne L, Houshyar H, Lafleur J, Ramachandran C, O'Neill GP, Slipetz D, Tan CM.

Am J Respir Cell Mol Biol. 2008 Jul;39(1):26-35. doi: 10.1165/rcmb.2007-0240OC. Epub 2008 Feb 7.

PMID:
18258919
2.

Mechanism of interleukin-25 (IL-17E)-induced pulmonary inflammation and airways hyper-reactivity.

Sharkhuu T, Matthaei KI, Forbes E, Mahalingam S, Hogan SP, Hansbro PM, Foster PS.

Clin Exp Allergy. 2006 Dec;36(12):1575-83.

PMID:
17177681
3.

Contribution of IL-18-induced innate T cell activation to airway inflammation with mucus hypersecretion and airway hyperresponsiveness.

Ishikawa Y, Yoshimoto T, Nakanishi K.

Int Immunol. 2006 Jun;18(6):847-55. Epub 2006 Apr 12.

PMID:
16611648
4.

Interleukin-13 regulates secretion of the tumor growth factor-{beta} superfamily cytokine activin A in allergic airway inflammation.

Hardy CL, Lemasurier JS, Olsson F, Dang T, Yao J, Yang M, Plebanski M, Phillips DJ, Mollard R, Rolland JM, O'Hehir RE.

Am J Respir Cell Mol Biol. 2010 Jun;42(6):667-75. doi: 10.1165/rcmb.2008-0429OC. Epub 2009 Jul 27.

PMID:
19635933
5.

Purinergic receptor type 6 contributes to airway inflammation and remodeling in experimental allergic airway inflammation.

Vieira RP, Müller T, Grimm M, von Gernler V, Vetter B, Dürk T, Cicko S, Ayata CK, Sorichter S, Robaye B, Zeiser R, Ferrari D, Kirschbaum A, Zissel G, Virchow JC, Boeynaems JM, Idzko M.

Am J Respir Crit Care Med. 2011 Jul 15;184(2):215-23. doi: 10.1164/rccm.201011-1762OC. Epub 2011 Apr 21.

PMID:
21512170
6.

Respiratory syncytial virus-induced airway hyperresponsiveness is independent of IL-13 compared with that induced by allergen.

Park JW, Taube C, Yang ES, Joetham A, Balhorn A, Takeda K, Miyahara N, Dakhama A, Donaldson DD, Gelfand EW.

J Allergy Clin Immunol. 2003 Dec;112(6):1078-87.

PMID:
14657862
7.

Effects of (±)-praeruptorin A on airway inflammation, airway hyperresponsiveness and NF-κB signaling pathway in a mouse model of allergic airway disease.

Xiong Y, Wang J, Wu F, Li J, Zhou L, Kong L.

Eur J Pharmacol. 2012 May 15;683(1-3):316-24. doi: 10.1016/j.ejphar.2012.03.004. Epub 2012 Mar 15.

PMID:
22449378
8.

The Th2 lymphocyte products IL-4 and IL-13 rapidly induce airway hyperresponsiveness through direct effects on resident airway cells.

Venkayya R, Lam M, Willkom M, Grünig G, Corry DB, Erle DJ.

Am J Respir Cell Mol Biol. 2002 Feb;26(2):202-8.

PMID:
11804871
9.
10.

Critical role for IL-13 in the development of allergen-induced airway hyperreactivity.

Walter DM, McIntire JJ, Berry G, McKenzie AN, Donaldson DD, DeKruyff RH, Umetsu DT.

J Immunol. 2001 Oct 15;167(8):4668-75.

11.

Inhibitory effects of Duchesnea chrysantha extract on ovalbumin-induced lung inflammation in a mouse model of asthma.

Yang EJ, Lee JS, Yun CY, Kim JH, Kim JS, Kim DH, Kim IS.

J Ethnopharmacol. 2008 Jun 19;118(1):102-7. doi: 10.1016/j.jep.2008.03.012. Epub 2008 Mar 25.

PMID:
18485641
12.

Synergistic therapeutic effects of combined adenovirus-mediated interleukin-10 and interleukin-12 gene therapy on airway inflammation in asthmatic mice.

Hsu CY, Liu HE, Sheu FY, Leu SJ, Chiang BL, Hsiao G, Lee YL.

J Gene Med. 2010 Jan;12(1):11-21. doi: 10.1002/jgm.1408.

PMID:
19866481
13.

Inhibition of airway inflammation, hyperresponsiveness and remodeling by soy isoflavone in a murine model of allergic asthma.

Bao ZS, Hong L, Guan Y, Dong XW, Zheng HS, Tan GL, Xie QM.

Int Immunopharmacol. 2011 Aug;11(8):899-906. doi: 10.1016/j.intimp.2011.02.001. Epub 2011 Feb 26.

PMID:
21354484
14.

Respiratory syncytial virus infection does not increase allergen-induced type 2 cytokine production, yet increases airway hyperresponsiveness in mice.

Peebles RS Jr, Sheller JR, Collins RD, Jarzecka AK, Mitchell DB, Parker RA, Graham BS.

J Med Virol. 2001 Feb;63(2):178-88.

PMID:
11170055
15.

Preventive and curative glycoside kaempferol treatments attenuate the TH2-driven allergic airway disease.

Medeiros KC, Faustino L, Borduchi E, Nascimento RJ, Silva TM, Gomes E, Piuvezam MR, Russo M.

Int Immunopharmacol. 2009 Dec;9(13-14):1540-8. doi: 10.1016/j.intimp.2009.09.005. Epub 2009 Sep 12.

PMID:
19755174
16.

Adenovirus expressing interleukin-1 receptor antagonist alleviates allergic airway inflammation in a murine model of asthma.

Wang CC, Fu CL, Yang YH, Lo YC, Wang LC, Chuang YH, Chang DM, Chiang BL.

Gene Ther. 2006 Oct;13(19):1414-21. Epub 2006 May 25.

PMID:
16724092
17.

Anti-inflammatory activity of inhaled IL-4 receptor-alpha antisense oligonucleotide in mice.

Karras JG, Crosby JR, Guha M, Tung D, Miller DA, Gaarde WA, Geary RS, Monia BP, Gregory SA.

Am J Respir Cell Mol Biol. 2007 Mar;36(3):276-85. Epub 2006 Sep 21.

PMID:
16990616
18.

A murine IL-4 receptor antagonist that inhibits IL-4- and IL-13-induced responses prevents antigen-induced airway eosinophilia and airway hyperresponsiveness.

Tomkinson A, Duez C, Cieslewicz G, Pratt JC, Joetham A, Shanafelt MC, Gundel R, Gelfand EW.

J Immunol. 2001 May 1;166(9):5792-800.

19.

Direct effects of interleukin-13 on epithelial cells cause airway hyperreactivity and mucus overproduction in asthma.

Kuperman DA, Huang X, Koth LL, Chang GH, Dolganov GM, Zhu Z, Elias JA, Sheppard D, Erle DJ.

Nat Med. 2002 Aug;8(8):885-9. Epub 2002 Jul 1.

PMID:
12091879
20.

Anti-IL-13 monoclonal antibody inhibits airway hyperresponsiveness, inflammation and airway remodeling.

Yang G, Volk A, Petley T, Emmell E, Giles-Komar J, Shang X, Li J, Das AM, Shealy D, Griswold DE, Li L.

Cytokine. 2004 Dec 21;28(6):224-32.

PMID:
15566951

Supplemental Content

Support Center